Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study

Stavros Apostolakis, Deirdre A Lane, Yutao Guo, Harry Buller, Gregory Y H Lip

Research output: Contribution to journalArticlepeer-review

280 Citations (Scopus)

Abstract

The objective of this study was to compare the predictive performance of bleeding risk-estimation tools in a cohort of patients with atrial fibrillation (AF) undergoing anticoagulation.
Original languageEnglish
Pages (from-to)861-7
Number of pages7
JournalJournal of the American College of Cardiology
Volume60
Issue number9
DOIs
Publication statusPublished - 28 Aug 2012

Bibliographical note

Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Keywords

  • Randomized Controlled Trials as Topic
  • Anticoagulants
  • Humans
  • Aged
  • Predictive Value of Tests
  • Middle Aged
  • Warfarin
  • Atrial Fibrillation
  • Hemorrhage
  • Male
  • Female
  • Risk Assessment

Fingerprint

Dive into the research topics of 'Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study'. Together they form a unique fingerprint.

Cite this